Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine

ORCID: 0000-0001-8901-7850

Publication year:
All
31 - 40 out of 48Page size: 10
  1. 2008
  2. Published

    Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption

    Gordin, F. M., Roediger, M. P., Girard, P., Lundgren, Jens, Miro, J. M., Palfreeman, A., Rodriguez-Barradas, M. C., Wolff, M. J., Easterbrook, P. J., Clezy, K. & Slater, L. N., 2008, In: American Journal of Respiratory and Critical Care Medicine. 178, 6, p. 630-6 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networks

    Kjaer, J., Høj, L., Fox, Z. & Lundgren, Jens, 2008, In: HIV Medicine. 9, 8, p. 642-52 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Procalcitonin in liver transplant patients--yet another stone turned

    Jensen , Jens-Ulrik Stæhr & Lundgren, Jens, 2008, In: Critical Care (Online Edition). 12, 1, p. 108

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999

    Mocroft, A., Horban, A., Clotet, B., d'Arminio Monforte, A., Bogner, J. R., Aldins, P., Staub, T., Antunes, F., Katlama, C., Lundgren, Jens & Eurosida Study Group, E. S. G., 2008, In: HIV Medicine. 9, 1, p. 41-6 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Response to combination antiretroviral therapy: variation by age

    Lundgren, Jens & Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group, C. O. O. H. E. R. E. (. S. G., 2008, In: AIDS. 22, 12, p. 1463-73 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial

    El-Sadr, W. M., Grund, B., Neuhaus, J., Babiker, A., Cohen, C. J., Darbyshire, J., Emery, S., Lundgren, Jens, Phillips, A., Neaton, J. D. & SMART Study Group, S. S. G., 2008, In: Annals of Internal Medicine. 149, 5, p. 289-99 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe

    Soriano, V., Mocroft, A., Rockstroh, J., Ledergerber, B., Knysz, B., Chaplinskas, S., Peters, L., Karlsson, A., Katlama, C., Toro, C., Kupfer, B., Vogel, M., Lundgren, Jens & Eurosida Study Group, E. S. G., 2008, In: Journal of Infectious Diseases. 198, 9, p. 1337-44 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary

    Grinspoon, S. K., Grunfeld, C., Kotler, D. P., Currier, J. S., Lundgren, Jens, Dubé, M. P., Lipshultz, S. E., Hsue, P. Y., Squires, K., Schambelan, M., Wilson, P. W. F., Yarasheski, K. E., Hadigan, C. M., Stein, J. H. & Eckel, R. H., 2008, In: Circulation. 118, 2, p. 198-210 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results

    Podlekareva, Daria, Bannister, W., Mocroft, A., Abrosimova, L., Karpov, I., Lundgren, Jens, Kirk, Ole & Eurosida Study Group, E. S. G., 2008, In: Central European Journal of Public Health. 16, 3, p. 99-105 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients

    Jensen, J-U., Lundgren, B., Hein, L., Mohr, T., Petersen, P. L., Andersen, L. H., Lauritsen, A. Ø., Hougaard, S., Mantoni, T., Bømler, B., Thornberg, K. J., Thormar, K., Løken, J., Steensen, M., Carl, P., Petersen, J. A., Tousi, H., Søe-Jensen, P., Bestle, M., Hestad, S. & 9 others, Andersen, M. H., Fjeldborg, P., Larsen, K. M., Rossau, C. D., Thomsen, C. B., Ostergaard, C., Kjaer, J., Grarup, J. & Lundgren, Jens, 2008, In: BMC Infectious Diseases. 8, p. 91

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 Next

ID: 13961